The company said it entered into an Agreement and Plan of Merger with Sadie Merger Sub, Inc. and Axonics, Inc. on January 8, 2024. Under the deal, Axonics would survive the merger as a wholly owned subsidiary of the company.

1. 01

   The company said it entered into an Agreement and Plan of Merger with Sadie Merger Sub, Inc. and Axonics, Inc. on January 8, 2024. Under the deal, Axonics would survive the merger as a wholly owned subsidiary of the company.

2. 02

   The company said that on April 3, 2024, it and Axonics each received a request for additional information from the U.S. Federal Trade Commission (FTC) in connection with the FTC's review of the merger. The request is referred to as the Second Request.

3. 03

   The company said the Second Request extends the waiting period under the HSR Act until 30 days after the company and Axonics have substantially complied with the Second Request. It explained that the exceptions are a voluntary extension by the parties or early termination by the FTC.

4. 04

   The company said it expects the merger to be completed in the second half of 2024. It explained that this is subject to the expiration or termination of the HSR Act waiting period and the satisfaction (or waiver) of other customary closing conditions.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.